Cancers, Vol. 11, Pages 1665: Unique Molecular Features in High-Risk Histology Endometrial Cancers
Cancers, Vol. 11, Pages 1665: Unique Molecular Features in High-Risk Histology Endometrial Cancers
Cancers doi: 10.3390/cancers11111665
Authors:
Pooja Pandita
Xiyin Wang
Devin E. Jones
Kaitlyn Collins
Shannon M. Hawkins
Endometrial cancer is the most common gynecologic malignancy in the United States and the sixth most common cancer in women worldwide. Fortunately, most women who develop endometrial cancer have low-grade early-stage endometrioid carcinomas, and simple hysterectomy is curative. Unfortunately, 15% of women with endometrial cancer will develop high-risk histologic tumors including uterine carcinosarcoma or high-grade endometrioid, clear cell, or serous carcinomas. These high-risk histologic tumors account for more than 50% of deaths from this disease. In this review, we will highlight the biologic differences between low- and high-risk carcinomas with a focus on the cell of origin, early precursor lesions including atrophic and proliferative endometrium, and the potential role of stem cells. We will discuss treatment, including standard of care therapy, hormonal therapy, and precision medicine-based or targeted molecular therapies. We will also discuss the impact and need for model systems. The molecular underpinnings behind this high death to incidence ratio are important to understand and improve outcomes.
Source: Cancers - Category: Cancer & Oncology Authors: Pooja Pandita Xiyin Wang Devin E. Jones Kaitlyn Collins Shannon M. Hawkins Tags: Review Source Type: research
More News: Cancer | Cancer & Oncology | Cancer of the Uterus | Carcinoma | Carcinosarcoma | Endometrial Cancer | Hormonal Therapy | Hormones | Hysterectomy | Molecular Biology | Serous Carcinoma | Stem Cell Therapy | Stem Cells | USA Health | Women